Selected research
Market Outlook & Growth Opportunities
Global Vitamin K1 Injection Market Outlook and Growth Opportunities 2026
Market perspective
The global Vitamin K1 Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Vitamin K1 Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Vitamin K1 Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Vitamin K1 Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Vitamin K1 Injection market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Vitamin K1 Injection market include Suicheng Pharmaceutical, Jiangsu Huayang Pharmaceutical, Cheng Yi Pharmaceutical, Brilliant Pharmaceutical, Wuhu Kangqi Pharmaceuticals, Innopharma and AdvaCare, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Vitamin K1 Injection market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Vitamin K1 Injection and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Vitamin K1 Injection sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Vitamin K1 Injection market size, projected growth trends, production technologies, key applications, and end-use industries.
Vitamin K1 Injection Segment by Company
Suicheng Pharmaceutical
Jiangsu Huayang Pharmaceutical
Cheng Yi Pharmaceutical
Brilliant Pharmaceutical
Wuhu Kangqi Pharmaceuticals
Innopharma
AdvaCare
Vitamin K1 Injection Segment by Type
2mg/mL
5mg/mL
10mg/mL
Vitamin K1 Injection Segment by Application
Hospital
Clinic
Others
Vitamin K1 Injection Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global Vitamin K1 Injection status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Vitamin K1 Injection market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Vitamin K1 Injection significant trends, drivers, influence factors in global and regions.
6. To analyze Vitamin K1 Injection competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Vitamin K1 Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Vitamin K1 Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Vitamin K1 Injection.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Vitamin K1 Injection market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Vitamin K1 Injection industry.
Chapter 3: Detailed analysis of Vitamin K1 Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Vitamin K1 Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Vitamin K1 Injection in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- 2mg/mL
- 5mg/mL
- 10mg/mL
Applications
- Hospital
- Clinic
- Others
Companies covered
- Suicheng Pharmaceutical
- Jiangsu Huayang Pharmaceutical
- Cheng Yi Pharmaceutical
- Brilliant Pharmaceutical
- Wuhu Kangqi Pharmaceuticals
- Innopharma
- AdvaCare
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Vitamin K1 Injection Sales Value (2021-2032)
- 1.2.2 Global Vitamin K1 Injection Sales Volume (2021-2032)
- 1.2.3 Global Vitamin K1 Injection Sales Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Vitamin K1 Injection Market Dynamics
- 2.1 Vitamin K1 Injection Industry Trends
- 2.2 Vitamin K1 Injection Industry Drivers
- 2.3 Vitamin K1 Injection Industry Opportunities and Challenges
- 2.4 Vitamin K1 Injection Industry Restraints
3 Vitamin K1 Injection Market by Company
- 3.1 Global Vitamin K1 Injection Company Revenue Ranking in 2025
- 3.2 Global Vitamin K1 Injection Revenue by Company (2021-2026)
- 3.3 Global Vitamin K1 Injection Sales Volume by Company (2021-2026)
- 3.4 Global Vitamin K1 Injection Average Price by Company (2021-2026)
- 3.5 Global Vitamin K1 Injection Company Ranking (2024-2026)
- 3.6 Global Vitamin K1 Injection Company Manufacturing Base and Headquarters
- 3.7 Global Vitamin K1 Injection Company Product Type and Application
- 3.8 Global Vitamin K1 Injection Company Establishment Date
- 3.9 Market Competitive Analysis
- 3.9.1 Global Vitamin K1 Injection Market Concentration Ratio (CR5 and HHI)
- 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.9.3 2025 Vitamin K1 Injection Tier 1, Tier 2, and Tier 3 Companies
- 3.10 Mergers and Acquisitions Expansion
4 Vitamin K1 Injection Market by Type
- 4.1 Vitamin K1 Injection Type Introduction
- 4.1.1 2mg/mL
- 4.1.2 5mg/mL
- 4.1.3 10mg/mL
- 4.2 Global Vitamin K1 Injection Sales Volume by Type
- 4.2.1 Global Vitamin K1 Injection Sales Volume by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Vitamin K1 Injection Sales Volume by Type (2021-2032)
- 4.2.3 Global Vitamin K1 Injection Sales Volume Share by Type (2021-2032)
- 4.3 Global Vitamin K1 Injection Sales Value by Type
- 4.3.1 Global Vitamin K1 Injection Sales Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Vitamin K1 Injection Sales Value by Type (2021-2032)
- 4.3.3 Global Vitamin K1 Injection Sales Value Share by Type (2021-2032)
5 Vitamin K1 Injection Market by Application
- 5.1 Vitamin K1 Injection Application Introduction
- 5.1.1 Hospital
- 5.1.2 Clinic
- 5.1.3 Others
- 5.2 Global Vitamin K1 Injection Sales Volume by Application
- 5.2.1 Global Vitamin K1 Injection Sales Volume by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Vitamin K1 Injection Sales Volume by Application (2021-2032)
- 5.2.3 Global Vitamin K1 Injection Sales Volume Share by Application (2021-2032)
- 5.3 Global Vitamin K1 Injection Sales Value by Application
- 5.3.1 Global Vitamin K1 Injection Sales Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Vitamin K1 Injection Sales Value by Application (2021-2032)
- 5.3.3 Global Vitamin K1 Injection Sales Value Share by Application (2021-2032)
6 Vitamin K1 Injection Regional Sales and Value Analysis
- 6.1 Global Vitamin K1 Injection Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Vitamin K1 Injection Sales by Region (2021-2032)
- 6.2.1 Global Vitamin K1 Injection Sales by Region: 2021-2026
- 6.2.2 Global Vitamin K1 Injection Sales by Region (2027-2032)
- 6.3 Global Vitamin K1 Injection Sales Value by Region: 2021 VS 2025 VS 2032
- 6.4 Global Vitamin K1 Injection Sales Value by Region (2021-2032)
- 6.4.1 Global Vitamin K1 Injection Sales Value by Region: 2021-2026
- 6.4.2 Global Vitamin K1 Injection Sales Value by Region (2027-2032)
- 6.5 Global Vitamin K1 Injection Market Price Analysis by Region (2021-2026)
- 6.6 North America
- 6.6.1 North America Vitamin K1 Injection Sales Value (2021-2032)
- 6.6.2 North America Vitamin K1 Injection Sales Value Share by Country, 2025 VS 2032
- 6.7 Europe
- 6.7.1 Europe Vitamin K1 Injection Sales Value (2021-2032)
- 6.7.2 Europe Vitamin K1 Injection Sales Value Share by Country, 2025 VS 2032
- 6.8 Asia-Pacific
- 6.8.1 Asia-Pacific Vitamin K1 Injection Sales Value (2021-2032)
- 6.8.2 Asia-Pacific Vitamin K1 Injection Sales Value Share by Country, 2025 VS 2032
- 6.9 South America
- 6.9.1 South America Vitamin K1 Injection Sales Value (2021-2032)
- 6.9.2 South America Vitamin K1 Injection Sales Value Share by Country, 2025 VS 2032
- 6.10 Middle East & Africa
- 6.10.1 Middle East & Africa Vitamin K1 Injection Sales Value (2021-2032)
- 6.10.2 Middle East & Africa Vitamin K1 Injection Sales Value Share by Country, 2025 VS 2032
7 Vitamin K1 Injection Country-level Sales and Value Analysis
- 7.1 Global Vitamin K1 Injection Sales by Country: 2021 VS 2025 VS 2032
- 7.2 Global Vitamin K1 Injection Sales Value by Country: 2021 VS 2025 VS 2032
- 7.3 Global Vitamin K1 Injection Sales by Country (2021-2032)
- 7.3.1 Global Vitamin K1 Injection Sales by Country (2021-2026)
- 7.3.2 Global Vitamin K1 Injection Sales by Country (2027-2032)
- 7.4 Global Vitamin K1 Injection Sales Value by Country (2021-2032)
- 7.4.1 Global Vitamin K1 Injection Sales Value by Country (2021-2026)
- 7.4.2 Global Vitamin K1 Injection Sales Value by Country (2027-2032)
- 7.5 USA
- 7.5.1 USA Vitamin K1 Injection Sales Value Growth Rate (2021-2032)
- 7.5.2 USA Vitamin K1 Injection Sales Value Share by Type, 2025 VS 2032
- 7.5.3 USA Vitamin K1 Injection Sales Value Share by Application, 2025 VS 2032
- 7.6 Canada
- 7.6.1 Canada Vitamin K1 Injection Sales Value Growth Rate (2021-2032)
- 7.6.2 Canada Vitamin K1 Injection Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Canada Vitamin K1 Injection Sales Value Share by Application, 2025 VS 2032
- 7.7 Mexico
- 7.6.1 Mexico Vitamin K1 Injection Sales Value Growth Rate (2021-2032)
- 7.6.2 Mexico Vitamin K1 Injection Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Mexico Vitamin K1 Injection Sales Value Share by Application, 2025 VS 2032
- 7.8 Germany
- 7.8.1 Germany Vitamin K1 Injection Sales Value Growth Rate (2021-2032)
- 7.8.2 Germany Vitamin K1 Injection Sales Value Share by Type, 2025 VS 2032
- 7.8.3 Germany Vitamin K1 Injection Sales Value Share by Application, 2025 VS 2032
- 7.9 France
- 7.9.1 France Vitamin K1 Injection Sales Value Growth Rate (2021-2032)
- 7.9.2 France Vitamin K1 Injection Sales Value Share by Type, 2025 VS 2032
- 7.9.3 France Vitamin K1 Injection Sales Value Share by Application, 2025 VS 2032
- 7.10 U.K.
- 7.10.1 U.K. Vitamin K1 Injection Sales Value Growth Rate (2021-2032)
- 7.10.2 U.K. Vitamin K1 Injection Sales Value Share by Type, 2025 VS 2032
- 7.10.3 U.K. Vitamin K1 Injection Sales Value Share by Application, 2025 VS 2032
- 7.11 Italy
- 7.11.1 Italy Vitamin K1 Injection Sales Value Growth Rate (2021-2032)
- 7.11.2 Italy Vitamin K1 Injection Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Italy Vitamin K1 Injection Sales Value Share by Application, 2025 VS 2032
- 7.12 Spain
- 7.12.1 Spain Vitamin K1 Injection Sales Value Growth Rate (2021-2032)
- 7.12.2 Spain Vitamin K1 Injection Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Spain Vitamin K1 Injection Sales Value Share by Application, 2025 VS 2032
- 7.13 Russia
- 7.13.1 Russia Vitamin K1 Injection Sales Value Growth Rate (2021-2032)
- 7.13.2 Russia Vitamin K1 Injection Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Russia Vitamin K1 Injection Sales Value Share by Application, 2025 VS 2032
- 7.14 Netherlands
- 7.14.1 Netherlands Vitamin K1 Injection Sales Value Growth Rate (2021-2032)
- 7.14.2 Netherlands Vitamin K1 Injection Sales Value Share by Type, 2025 VS 2032
- 7.14.3 Netherlands Vitamin K1 Injection Sales Value Share by Application, 2025 VS 2032
- 7.15 Nordic Countries
- 7.15.1 Nordic Countries Vitamin K1 Injection Sales Value Growth Rate (2021-2032)
- 7.15.2 Nordic Countries Vitamin K1 Injection Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Nordic Countries Vitamin K1 Injection Sales Value Share by Application, 2025 VS 2032
- 7.16 China
- 7.16.1 China Vitamin K1 Injection Sales Value Growth Rate (2021-2032)
- 7.16.2 China Vitamin K1 Injection Sales Value Share by Type, 2025 VS 2032
- 7.16.3 China Vitamin K1 Injection Sales Value Share by Application, 2025 VS 2032
- 7.17 Japan
- 7.17.1 Japan Vitamin K1 Injection Sales Value Growth Rate (2021-2032)
- 7.17.2 Japan Vitamin K1 Injection Sales Value Share by Type, 2025 VS 2032
- 7.17.3 Japan Vitamin K1 Injection Sales Value Share by Application, 2025 VS 2032
- 7.18 South Korea
- 7.18.1 South Korea Vitamin K1 Injection Sales Value Growth Rate (2021-2032)
- 7.18.2 South Korea Vitamin K1 Injection Sales Value Share by Type, 2025 VS 2032
- 7.18.3 South Korea Vitamin K1 Injection Sales Value Share by Application, 2025 VS 2032
- 7.19 India
- 7.19.1 India Vitamin K1 Injection Sales Value Growth Rate (2021-2032)
- 7.19.2 India Vitamin K1 Injection Sales Value Share by Type, 2025 VS 2032
- 7.19.3 India Vitamin K1 Injection Sales Value Share by Application, 2025 VS 2032
- 7.20 Australia
- 7.20.1 Australia Vitamin K1 Injection Sales Value Growth Rate (2021-2032)
- 7.20.2 Australia Vitamin K1 Injection Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Australia Vitamin K1 Injection Sales Value Share by Application, 2025 VS 2032
- 7.21 Southeast Asia
- 7.21.1 Southeast Asia Vitamin K1 Injection Sales Value Growth Rate (2021-2032)
- 7.21.2 Southeast Asia Vitamin K1 Injection Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Southeast Asia Vitamin K1 Injection Sales Value Share by Application, 2025 VS 2032
- 7.22 Brazil
- 7.22.1 Brazil Vitamin K1 Injection Sales Value Growth Rate (2021-2032)
- 7.22.2 Brazil Vitamin K1 Injection Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Brazil Vitamin K1 Injection Sales Value Share by Application, 2025 VS 2032
- 7.23 Argentina
- 7.23.1 Argentina Vitamin K1 Injection Sales Value Growth Rate (2021-2032)
- 7.23.2 Argentina Vitamin K1 Injection Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Argentina Vitamin K1 Injection Sales Value Share by Application, 2025 VS 2032
- 7.24 Chile
- 7.24.1 Chile Vitamin K1 Injection Sales Value Growth Rate (2021-2032)
- 7.24.2 Chile Vitamin K1 Injection Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Chile Vitamin K1 Injection Sales Value Share by Application, 2025 VS 2032
- 7.25 Colombia
- 7.25.1 Colombia Vitamin K1 Injection Sales Value Growth Rate (2021-2032)
- 7.25.2 Colombia Vitamin K1 Injection Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Colombia Vitamin K1 Injection Sales Value Share by Application, 2025 VS 2032
- 7.26 Peru
- 7.26.1 Peru Vitamin K1 Injection Sales Value Growth Rate (2021-2032)
- 7.26.2 Peru Vitamin K1 Injection Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Peru Vitamin K1 Injection Sales Value Share by Application, 2025 VS 2032
- 7.27 Saudi Arabia
- 7.27.1 Saudi Arabia Vitamin K1 Injection Sales Value Growth Rate (2021-2032)
- 7.27.2 Saudi Arabia Vitamin K1 Injection Sales Value Share by Type, 2025 VS 2032
- 7.27.3 Saudi Arabia Vitamin K1 Injection Sales Value Share by Application, 2025 VS 2032
- 7.28 Israel
- 7.28.1 Israel Vitamin K1 Injection Sales Value Growth Rate (2021-2032)
- 7.28.2 Israel Vitamin K1 Injection Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Israel Vitamin K1 Injection Sales Value Share by Application, 2025 VS 2032
- 7.29 UAE
- 7.29.1 UAE Vitamin K1 Injection Sales Value Growth Rate (2021-2032)
- 7.29.2 UAE Vitamin K1 Injection Sales Value Share by Type, 2025 VS 2032
- 7.29.3 UAE Vitamin K1 Injection Sales Value Share by Application, 2025 VS 2032
- 7.30 Turkey
- 7.30.1 Turkey Vitamin K1 Injection Sales Value Growth Rate (2021-2032)
- 7.30.2 Turkey Vitamin K1 Injection Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Turkey Vitamin K1 Injection Sales Value Share by Application, 2025 VS 2032
- 7.31 Iran
- 7.31.1 Iran Vitamin K1 Injection Sales Value Growth Rate (2021-2032)
- 7.31.2 Iran Vitamin K1 Injection Sales Value Share by Type, 2025 VS 2032
- 7.31.3 Iran Vitamin K1 Injection Sales Value Share by Application, 2025 VS 2032
- 7.32 Egypt
- 7.32.1 Egypt Vitamin K1 Injection Sales Value Growth Rate (2021-2032)
- 7.32.2 Egypt Vitamin K1 Injection Sales Value Share by Type, 2025 VS 2032
- 7.32.3 Egypt Vitamin K1 Injection Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Suicheng Pharmaceutical
- 8.1.1 Suicheng Pharmaceutical Company Information
- 8.1.2 Suicheng Pharmaceutical Business Overview
- 8.1.3 Suicheng Pharmaceutical Vitamin K1 Injection Sales, Value and Gross Margin (2021-2026)
- 8.1.4 Suicheng Pharmaceutical Vitamin K1 Injection Product Portfolio
- 8.1.5 Suicheng Pharmaceutical Recent Developments
- 8.2 Jiangsu Huayang Pharmaceutical
- 8.2.1 Jiangsu Huayang Pharmaceutical Company Information
- 8.2.2 Jiangsu Huayang Pharmaceutical Business Overview
- 8.2.3 Jiangsu Huayang Pharmaceutical Vitamin K1 Injection Sales, Value and Gross Margin (2021-2026)
- 8.2.4 Jiangsu Huayang Pharmaceutical Vitamin K1 Injection Product Portfolio
- 8.2.5 Jiangsu Huayang Pharmaceutical Recent Developments
- 8.3 Cheng Yi Pharmaceutical
- 8.3.1 Cheng Yi Pharmaceutical Company Information
- 8.3.2 Cheng Yi Pharmaceutical Business Overview
- 8.3.3 Cheng Yi Pharmaceutical Vitamin K1 Injection Sales, Value and Gross Margin (2021-2026)
- 8.3.4 Cheng Yi Pharmaceutical Vitamin K1 Injection Product Portfolio
- 8.3.5 Cheng Yi Pharmaceutical Recent Developments
- 8.4 Brilliant Pharmaceutical
- 8.4.1 Brilliant Pharmaceutical Company Information
- 8.4.2 Brilliant Pharmaceutical Business Overview
- 8.4.3 Brilliant Pharmaceutical Vitamin K1 Injection Sales, Value and Gross Margin (2021-2026)
- 8.4.4 Brilliant Pharmaceutical Vitamin K1 Injection Product Portfolio
- 8.4.5 Brilliant Pharmaceutical Recent Developments
- 8.5 Wuhu Kangqi Pharmaceuticals
- 8.5.1 Wuhu Kangqi Pharmaceuticals Company Information
- 8.5.2 Wuhu Kangqi Pharmaceuticals Business Overview
- 8.5.3 Wuhu Kangqi Pharmaceuticals Vitamin K1 Injection Sales, Value and Gross Margin (2021-2026)
- 8.5.4 Wuhu Kangqi Pharmaceuticals Vitamin K1 Injection Product Portfolio
- 8.5.5 Wuhu Kangqi Pharmaceuticals Recent Developments
- 8.6 Innopharma
- 8.6.1 Innopharma Company Information
- 8.6.2 Innopharma Business Overview
- 8.6.3 Innopharma Vitamin K1 Injection Sales, Value and Gross Margin (2021-2026)
- 8.6.4 Innopharma Vitamin K1 Injection Product Portfolio
- 8.6.5 Innopharma Recent Developments
- 8.7 AdvaCare
- 8.7.1 AdvaCare Company Information
- 8.7.2 AdvaCare Business Overview
- 8.7.3 AdvaCare Vitamin K1 Injection Sales, Value and Gross Margin (2021-2026)
- 8.7.4 AdvaCare Vitamin K1 Injection Product Portfolio
- 8.7.5 AdvaCare Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Vitamin K1 Injection Value Chain Analysis
- 9.1.1 Vitamin K1 Injection Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Vitamin K1 Injection Sales Mode & Process
- 9.2 Vitamin K1 Injection Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Vitamin K1 Injection Distributors
- 9.2.3 Vitamin K1 Injection Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst